FDA Clearance Tracker · K243155
Single-Use Digital Flexible Ureteroscope(F-URS) (ZSR-URS-01, ZSR-URS-02, ZSR-URS-03, ZSR-URS-04)
Last checked: Nov 20, 2026Latest source record: Feb 11, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 11, 2025
Substantially Equivalent
Time to decision
134 days
Received Sep 30, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243155
- Device name
- Single-Use Digital Flexible Ureteroscope(F-URS) (ZSR-URS-01, ZSR-URS-02, ZSR-URS-03, ZSR-URS-04)
- Applicant location
- Dongguan, CN
- Received
- Sep 30, 2024
- Decided
- Feb 11, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & NephrologyUrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FGB. The earliest in FDA's data is K811535, decided Jun 23, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243155
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Dongguan Zsr Biomedical Technology Company Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241181 · Decided Aug 2, 2024 · 95 days after receipt
Device type: Endoscopic Access Overtube, Gastroenterology-Urology (FED) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.